| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.74B | $15.32B | $14.19B | $12.73B | $11.79B | $12.56B | $14.67B | $13.84B |
| Cost of Revenue | $8.90B | $9.14B | $8.77B | $7.51B | $6.89B | $7.03B | $8.61B | $8.01B |
| Gross Profit | $6.84B | $6.18B | $5.42B | $5.22B | $4.90B | $5.53B | $6.06B | $5.83B |
| Gross Margin | 43.47% | 40.32% | 38.20% | 41.01% | 41.54% | 44.01% | 41.31% | 42.13% |
| Operating Expenses | $4.23B | $4.02B | $3.81B | $3.54B | $3.19B | $3.62B | $4.08B | $3.63B |
| Operating Income | $2.61B | $2.16B | $1.61B | $1.68B | $1.71B | $1.91B | $1.98B | $2.20B |
| Operating Margin | 16.60% | 14.10% | 11.34% | 13.23% | 14.50% | 15.19% | 13.51% | 15.90% |
| Net Income | $2.11B | $1.37B | $1.09B | $1.13B | $-1.21B | $1.56B | $1.43B | $1.50B |
| Net Margin | 13.42% | 8.96% | 7.69% | 8.87% | -10.22% | 12.41% | 9.74% | 10.87% |
| EPS (Basic) | $7.43 | $4.82 | $3.83 | $3.95 | $-4.20 | $5.41 | $4.95 | $5.20 |
| EBITDA | $3.85B | $3.03B | $2.55B | $2.47B | $2.22B | $2.75B | $3.02B | $2.92B |
| Stock Option Compensation Expense | $134.80M | $95.10M | $87.80M | $89.50M | $82.10M | $84.00M | $94.40M | $90.50M |
| Price To Earnings Ratio | 31.54 | 41.19 | 38.03 | 59.44 | -51.53 | 35.67 | 29.76 | 25.83 |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | $66.62B | $56.53B | $41.51B | $67.16B | $62.10B | $55.60B | $42.53B | $38.86B |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $22.39B | $21.85B | $21.46B | $21.21B | $18.13B | $20.87B | $20.07B | $19.96B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $13.60B | $13.77B | $14.21B | $13.95B | $11.92B | $12.14B | $12.02B | $12.27B |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $8.76B | $8.04B | $7.24B | $7.22B | $6.17B | $8.69B | $8.00B | $7.62B |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $8.76B | $8.04B | $7.24B | $7.22B | $6.17B | $8.69B | $8.00B | $7.62B |
| Total Liabilities & Stockholders Equity | $22.39B | $21.85B | $21.46B | $21.21B | $18.13B | $20.87B | $20.07B | $19.96B |
| Book Value Per Share | $30.92 | $28.32 | $25.45 | $25.33 | $21.61 | $30.29 | $27.91 | $26.55 |
| Tangible Book Value Per Share | $-8.54 | $-12.52 | $-15.55 | $-17.59 | $-9.69 | $0.80 | $-9.78 | $-12.07 |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 9.44% | 6.28% | 5.09% | 5.33% | -6.65% | 7.47% | 7.12% | 7.54% |
| Return on Equity | 24.12% | 17.06% | 15.09% | 15.64% | -19.54% | 17.95% | 17.86% | 19.75% |
| Return on Invested Capital | 11.80% | 9.39% | 7.44% | 7.50% | 9.45% | 8.96% | 9.23% | 11.09% |
| Quick Ratio | 0.95 | 0.95 | 0.88 | 0.90 | 1.31 | 1.03 | 0.85 | 0.92 |
| Current Ratio | 1.26 | 1.30 | 1.30 | 1.32 | 1.75 | 1.33 | 1.27 | 1.34 |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $2.11B | $1.37B | $1.09B | $1.13B | $-1.21B | $1.56B | $1.43B | $1.50B |
| Depreciation | $935.40M | $923.60M | $938.70M | $843.10M | $812.70M | $775.30M | $938.30M | $893.30M |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $2.81B | $2.41B | $1.79B | $2.06B | $1.86B | $2.42B | $2.28B | $2.09B |
| Capital Expenditures | $994.50M | $774.80M | $712.80M | $643.00M | $489.00M | $731.30M | $847.10M | $868.60M |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | $664.30M | $617.30M | $602.80M | $566.40M | $560.80M | $552.90M | $496.50M | $448.70M |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | $986.50M | $13.70M | $518.20M | $106.60M | $146.20M | $353.70M | $562.40M | $600.30M |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | $1.82B | $1.64B | $1.08B | $1.42B | $1.37B | $1.69B | $1.43B | $1.22B |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
Why it moved over time
Ecolab (ECL) declared a quarterly cash dividend of $0.73 per share, payable Oct. 15 to shareholders of record Sept. 15, a capital-return signal that affects investor income and yield expectations.
Key fact: The board declared a regular quarterly cash dividend of $0.73 per common share, to be paid Oct. 15, 2026, to shareholders of record at the close of business on Sept. 15, 2026.
businesswire.com: Ecolab Declares Cash DividendEcolab reported Q2 adjusted EPS up 11% with 5% organic sales growth, beat estimates and raised 2026 adjusted EPS guidance to $8.05–$8.25, signaling stronger-than-expected profit and sales momentum.
Key fact: Q2 adjusted EPS $2.09 (+11%) and 2026 adjusted EPS guidance raised to $8.05–$8.25 (+7%–10%).
seekingalpha.com: Ecolab Inc. (ECL) Q2 2026 Earnings Call Transcript